These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6123862)

  • 1. Inactivating Lassa and Marburg/Ebola viruses.
    Pereira MS
    Lancet; 1982 Jul; 2(8290):155. PubMed ID: 6123862
    [No Abstract]   [Full Text] [Related]  

  • 2. Physical and chemical methods of inactivating Lassa virus.
    Lloyd G; Bowen ET; Slade JH
    Lancet; 1982 May; 1(8280):1046-8. PubMed ID: 6122855
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of betapropionolactone inactivated Ebola, Marburg and Lassa intracellular antigens in immunofluorescent antibody assay.
    Van der Groen G; Elliot LH
    Ann Soc Belg Med Trop; 1982 Mar; 62(1):49-54. PubMed ID: 7049096
    [No Abstract]   [Full Text] [Related]  

  • 4. Inactivation of Lassa, Marburg, and Ebola viruses by gamma irradiation.
    Elliott LH; McCormick JB; Johnson KM
    J Clin Microbiol; 1982 Oct; 16(4):704-8. PubMed ID: 7153317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Research with the Marburg, Lassa and Ebola viruses].
    Pshenichnov VA; Makhlaĭ AA; Mikhaĭlov VV
    Vopr Virusol; 1993; 38(2):54-8. PubMed ID: 8059520
    [No Abstract]   [Full Text] [Related]  

  • 6. Modifications to indirect immunofluorescence tests on Lassa, Marburg, and Ebola material.
    van der Groen G; Kurata T; Mets C
    Lancet; 1983 Mar; 1(8325):654. PubMed ID: 6131336
    [No Abstract]   [Full Text] [Related]  

  • 7. [Marburg, Lassa and Ebola virus as cause of hemorrhagic fever].
    Siegert R
    Dtsch Med Wochenschr; 1978 Jul; 103(29):1176-81. PubMed ID: 352653
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of beta-propiolactone on routine biochemical investigations.
    Dooley BJ; Harling NP; Lloyd G; van Heyningen C
    Med Lab Sci; 1985 Oct; 42(4):318-21. PubMed ID: 4079681
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibodies to haemorrhagic fever viruses in Madagascar populations.
    Mathiot CC; Fontenille D; Georges AJ; Coulanges P
    Trans R Soc Trop Med Hyg; 1989; 83(3):407-9. PubMed ID: 2515626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physicochemical inactivation of Lassa, Ebola, and Marburg viruses and effect on clinical laboratory analyses.
    Mitchell SW; McCormick JB
    J Clin Microbiol; 1984 Sep; 20(3):486-9. PubMed ID: 6490832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of polyvalent viral immunofluorescent intracellular antigens and use in human serosurveys.
    Johnson KM; Elliott LH; Heymann DL
    J Clin Microbiol; 1981 Nov; 14(5):527-9. PubMed ID: 7031084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral hemorrhagic fever antibodies in Nigerian populations.
    Tomori O; Fabiyi A; Sorungbe A; Smith A; McCormick JB
    Am J Trop Med Hyg; 1988 Mar; 38(2):407-10. PubMed ID: 3128130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral haemorrhagic fevers caused by Lassa, Ebola and Marburg viruses.
    Curtis N
    Adv Exp Med Biol; 2006; 582():35-44. PubMed ID: 16802617
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of beta-propiolactone on some routine haematological tests.
    Atrah HI; Allardyce M; Davidson RJ
    Med Lab Sci; 1988 Oct; 45(4):308-11. PubMed ID: 3268715
    [No Abstract]   [Full Text] [Related]  

  • 15. The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry.
    Gehring G; Rohrmann K; Atenchong N; Mittler E; Becker S; Dahlmann F; Pöhlmann S; Vondran FW; David S; Manns MP; Ciesek S; von Hahn T
    J Antimicrob Chemother; 2014 Aug; 69(8):2123-31. PubMed ID: 24710028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemorrhagic fever in Gabon. I. Incidence of Lassa, Ebola and Marburg viruses in Haut-Ogooué.
    Ivanoff B; Duquesnoy P; Languillat G; Saluzzo JF; Georges A; Gonzalez JP; McCormick J
    Trans R Soc Trop Med Hyg; 1982; 76(6):719-20. PubMed ID: 7164137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Lassa virus and Ebola virus infection in host cells treated with the kinase inhibitors genistein and tyrphostin.
    Kolokoltsov AA; Adhikary S; Garver J; Johnson L; Davey RA; Vela EM
    Arch Virol; 2012 Jan; 157(1):121-7. PubMed ID: 21947546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemorrhagic (Marburg, Ebola, Lassa, and Bolivian) fevers: epidemiology, clinical pictures, and treatment].
    Borisevich IV; Markin VA; Firsova IV; Evseev AA; Khamitov RA; Maksimov VA
    Vopr Virusol; 2006; 51(5):8-16. PubMed ID: 17087059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The comparative characteristics of the genetic traits of the Lassa and Mopeia viruses].
    Erofeeva NI; Trofimov NM; Surikova LE; Vereshchako NS; Fidarov FM; Petkevich AS
    Vopr Virusol; 1990; 35(3):241-3. PubMed ID: 2219860
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of treatment strategies to combat Ebola and Marburg viruses.
    Paragas J; Geisbert TW
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):67-76. PubMed ID: 16441210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.